Biomimetic lipid nanoparticles mediated metabolic regulation and sonodynamic therapy for glioblastoma immunotherapy
{{output}}
Regulation of the tumor microenvironment (TME) represents a promising strategy to enhance immunotherapy for glioblastoma (GBM) immunotherapy. Lactate dehydrogenase A (LDHA) is an attractive metabolic target for TME modulation. We developed cRGD-decorated, GBM ... ...
